Company intelligence / Profile preview

Beacon Biosciences

Boston, Massachusetts, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Beacon Biosignals has commercial-stage AI-powered EEG diagnostic and monitoring solutions, including FDA-cleared devices for at-home sleep monitoring and digital biomarkers, and is actively partnered with industry leaders on clinical trials[4][5][3].

Therapeutic areas: PsychiatryNeurologyMetabolic Disorders
Modalities: DeviceArtificial Intelligence-based diagnostic platform
Industry: Physiological Monitoring

Partnerships

TakedaSkye BioscienceLongboard Pharmaceuticals

Beyond the preview

Go deeper on Beacon Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beacon Biosciences.

Explore the full profile